文献速递妇科

TET1通过激活Wnt/β-catenin信号通路抑制剂DKK1和SFRP2抑制卵巢癌细胞上皮-间质转化

TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
PubMed 文献 · Gynecol Oncol · 2017-08-26

本研究探讨TET1在上皮性卵巢癌中的作用,发现TET1表达与临床分期呈负相关,在6种上皮性卵巢癌细胞系中未检测到表达。过表达TET1可抑制SKOV3和OVCAR3细胞的集落形成、迁移和侵袭,逆转SKOV3细胞的上皮-间质转化,机制为TET1通过去甲基化上调Wnt/β-catenin通路拮抗剂DKK1和SFRP2。

要点

  • TET1表达与上皮性卵巢癌患者临床分期呈负相关。
  • 过表达TET1抑制SKOV3和OVCAR3细胞的集落形成、迁移和侵袭。
  • TET1通过去甲基化上调DKK1和SFRP2抑制Wnt/β-catenin信号通路。

核心结论

  • 本研究揭示TET1通过激活Wnt/β-catenin信号通路抑制剂DKK1和SFRP2,在上皮性卵巢癌中发挥强效的抑瘤作用。

研究设计与样本

  • 研究检测了上皮性卵巢癌细胞系和原发样本中TET1的表达,并通过体外功能研究揭示过表达TET1的生物学作用。

主要发现

  • 组织芯片显示TET1表达与上皮性卵巢癌患者临床分期呈负相关。
  • 6种上皮性卵巢癌细胞系中未检测到TET1表达。
  • 过表达TET1抑制SKOV3和OVCAR3细胞的集落形成、细胞迁移和侵袭。
  • 过表达TET1逆转SKOV3细胞的上皮-间质转化过程。
  • TET1通过去甲基化上调SFRP2和DKK1,抑制经典Wnt/β-catenin信号通路,并与抑制上皮-间质转化和癌细胞转移相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Epithelial ovarian cancer (EOC) is the deadliest type of ovarian cancer, but the mechanisms contributing to its tumorigenesis are not well understood. Herein, we will elucidate the role of Ten-eleven translocation 1 (TET1) in EOC development. METHODS: The expression of TET1 in EOC cell lines and primary samples was examined by western blot and immunohistochemistry. The biological role of ectopic TET1 overexpression was revealed by a series of in vitro functional studies. Its downstream signaling pathway was predicted by Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of microarray data. The methylation level and expression of Wnt/β-catenin signaling inhibitors Dikkopf 1 (DKK1) and secreted Fzd receptor protein 2 (SFRP2) were examined by Chromatin immunoprecipitation (ChIP) assay, Epimark™ 5hmC and 5mC level analysis and quantitative RT-PCR. Small interference RNA (siRNA) technology was used to investigate the biological roles of DKK1 and SFRP2. RESULTS: TET1 expression was inversely correlated with clinical stage in patients with EOC by tissue microarray (TMA). TET1 expression was undetected in 6 types of EOC cell lines. Ectopic expression of TET1 inhibited colony formation, cell migration and invasion in SKOV3 and OVCAR3 cells. Furthermore, TET1 overexpression reversed the epithelial-mesenchymal transition (EMT) process of SKOV3 cells. Mechanistically, TET1 potently inhibited canonical Wnt/β-catenin signaling by demethylating and upregulating two upstream antagonists of this pathway, SFRP2 and DKK1, which was associated with inhibition of EMT and cancer cell metastasis. CONCLUSION: This study uncovers that TET1 has potent tumor-suppressive effects in EOC by activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Duan H, Yan Z, Chen W, et al. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2. Gynecol Oncol. 2017. PMID: 28851501. doi:10.1016/j.ygyno.2017.08.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。